Open AccessEverolimus and Long-term Clinical Outcomes in Kidney Transplant Recipients: A Registry-based 10-year Follow-up of 5 Randomized Trials
Author(s) -
Tracey Ying,
Germaine Wong,
Wai H. Lim,
Philip Clayton,
John Kanellis,
Helen Pilmore,
Scott Campbell,
Philip J. O’Connell,
Graeme Russ,
Steven J. Chadban
Publication year - 2019
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000002499
Subject(s) - medicine , everolimus , hazard ratio , immunosuppression , randomized controlled trial , renal function , confidence interval , dialysis , interquartile range , kidney transplantation , transplantation , urology , surgery
Data regarding the long-term efficacy of everolimus-based immunosuppression for kidney transplantation are lacking. Existing randomized controlled trials are limited by short follow-up duration which limits capacity to assess impact on graft and patient survival.